Funding

Current Funding
Investigator(s) Type/Title Total Dollars*
Joe G.N. Garcia, MD P01/PPG (NIH/NHLBI), 2016–2021
Cytoskeletal Regulation of Lung Endothelial Pathobiology
$11,665,845
Joe G.N. Garcia, MD
Ting Wang, PhD
R01 (NIH/NHLBI), 2015-2019
nmMLCK Contributes to Genetic and Environmental Asthma Susceptibility
$1,571,001
Jason Yuan, MD/PhD
Franz Rischard, MD
Joe G.N. Garcia, MD
U01 (NIH/NHLBI), 2014-2019
Phenomic and Genomic Study to Subphenotype Hispanics with Pulmonary Hypertension
$1,439,239
Joe G.N. Garcia, MD
Francisco Moreno, MD
R25/PRIDE (NIH/NHLBI), 2014-2018
Advance Health Disparities Training Program in Heart, Lung, Blood, and Sleep Conditions (http://azpride.ahsc.arizona.edu)
$1,344,349
Pending Funding
Investigator(s) Type/Title Total Dollars*
Jason X.-J. Yuan, MD/PhD
Joe G.N. Garcia, MD
P01/PPG (NIH/NHLBI), 2017–2022
Novel Pathogenic Mechanisms in Pulmonary Arterial Hypertension
$11,627,622
Stephen M. Black, PhD
Joe G.N. Garcia, MD
P01/PPG (NIH/NHLBI), 2017–2022
Genetics, Epigenetics, and Post-Translational Modificiations in the Development of Ventilator-Induced Lung Injury (VILI)
$11,625,000
Jason X.-J. Yuan, MD/PhD
Joe G.N. Garcia, MD
R35 (NIH/NHLBI), 2017-2023
Ion Channels and Membrane Receptors in Pulmonary Arterial Hypertension
$4,605,000
Jian Wang, MD
Joe G.N. Garcia, MD (Co-I)
R01 (NIH/NHLBI), 2017-2022
Pathogenic Role of p53 in Hypoxia-induced Pulmonary Hypertension
$1,918,750
Ankit A. Desai, MD
Joe G.N. Garcia, MD (Co-I)
R01 (NIH/NHLBI), 2017-2022
The Pathological Role of Deubiquitinase, UCHL1, in Pulmonary Arterial Hypertension
$1,918,746
Louise Hecker, PhD
Joe G.N. Garcia, MD (Co-I)
R01 (NIH/NHLBI), 2017-2022
Role of NAMPT in Idiopathic Pulmonary Fibrosis
$1,892,724
Yves Lussier, MD
Joe G.N. Garcia, MD (Co-I)
R01 (NIH/NHLBI), 2017-2021
Rare disease precision medicine: scalable informatics methods to identify clinically relevant transcripts and pathways responding to perturbation in a single subject
$1,507,584
Christian Bime, MD
Joe G.N. Garcia, MD (Mentor)
K01 (NIH/NHLBI), 2017-2022
SELPLG as a Candidate Gene for ARDS
$707,535
Joe G.N. Garcia, MD
Jason X.-J. Yuan, MD/PhD
U01 Sub-Contract (NIH/NHLBI), 2017-2022
Regional Institutes Supporting Career Development of Clinical and Translational Scientists
$232,420
Select Past Funding
Investigator(s) Type/Title Total Dollars*
Joe G.N. Garcia, MD U01/PGA (NIH/NHLBI), 2000-2004
Applied Genomics in Cardiopulmonary Disease
$12,000,000
Joe G.N. Garcia, MD P01/PPG (NIH/NHLBI), 2008–2013
Cytoskeletal Regulation of Lung Endothelial Pathobiology
$11,806,085
Joe G.N. Garcia, MD P01/PPG (NIH/NHLBI), 2003–2008
Cytoskeletal Regulation of Lung Endothelial Pathobiology
$7,878,593
Joe G.N. Garcia, MD P01/PPG (NIH/NHLBI), 1998–2003
Molecular Regulation of Endothelial Cell Permeability
$5,984,000
Joe G.N. Garcia, MD T32 (NIH/NHLBI), 2002-2007
Multidisciplinary Training Program in Lung Diseases
$5,600,000
Joe G.N. Garcia, MD
Nati Natarajan, PhD
P01/PPG (NIH/NHLBI), 2011-2016 (Project 2, Core C, Core D)
Role of Sphingolipids in the Pathobiology of Lung Injury
$2,925,000
Julian Solway, MD
Joe G.N. Garcia, MD
U01/CTSA (NIH/NHLBI), 2007-2012
Re-engineering Translational Research at the University of Chicago
$2,607,700
Joe G.N. Garcia, MD R01 (NIH/NHLBI), 2008-2012
Regulation of Asthmatic Inflammation by Non-Muscle MLCK
$2,215,043
Joe G.N. Garcia, MD R01 (NIH/NHLBI), 2009-2013
Pathogenic Mechanisms of PBEF in Ventilator Induced Lung Injury
$2,041,675
Joe G.N. Garcia, MD R01 (NIH/NHLBI), 2015-2019 (relinquished in 2016)
Regulation of nmMLCK Structure and Function in ARDS
$1,994,145
Joe G.N. Garcia, MD
Roy Brower, MD
SCCOR (NIH/NHLBI), 2003–2008
Molecular Approaches to Ventilator-Associated Lung Injury: Novel Therapies for VALI-Induced Vascular Leak
$1,110,930
Jon S. Samet, MD
Joe G.N. Garcia, MD
EPA, 2005–2011
Health Effects of Particulate Matter
$925,000
Laura Koth, MD
Joe G.N. Garcia, MD
U01 (NIH/NHLBI), 2012-2015
Genomic Phenotyping and Mechanisms in Sarcoidosis and AAT
$782,587
Joe G.N. Garcia, MD
Aqualung Therapeutics, Corp
R41/STTR (NIH/NHLBI), 2011-2014
PBEF Neutralizing Humanized Monoclonal Antibodies As Novel Therapeutic Approaches
$630,000
Joe G.N. Garcia, MD U01 (NIH/NHLBI), 2014-2015
Genomic Signatures in Idiopathic Pulmonary Fibrosis
$592,693
Ivan O. Rosas, MD
Joe G.N. Garcia, MD
Augustine Choi, MD
U01 (NIH/NHLBI), 2011-2014
Carbon Monoxide for Idiopathic Pulmonary Fibrosis
$225,000
Ting Wang, PhD
Joe G.N. Garcia, MD
Parker B. Francis Fellowship, 2012-2015
Mechanisms of Particulate Matter-Induced Cardiac Arrhythmias
$156,000